(Q45137057)
Statements
1 reference
Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer (English)
1 reference
1 reference
B Besse
1 reference
L C Tsao
1 reference
D T Chao
1 reference
Y Fang
1 reference
J-C Soria
1 reference
S Almokadem
1 reference
16 August 2012
1 reference
1 reference
24
1 reference
1
1 reference
90-96
1 reference
Identifiers
1 reference
1 reference